glp-1 weight loss monroe in GA Unlocking The Power of GLP-1
Description
FLEX) injected directly into the OB (Fig
HOFFMANN-LA ROCHE LTD
CORRECTION (Oct
The US Food and Drug Administration approved this first-in-class medication for the management of type 2 diabetes (T2D) in 2022 [2], for the reduction of excess weight in adults with obesity or overweight in 2023 [3], and for moderate-to-severe obstructive sleep apnea (OSA) in people with obesity in 2024 [4]
It's a fierce debate, however
